.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Farmers Insurance
Federal Trade Commission
Dow
Johnson and Johnson
Medtronic
McKesson
Daiichi Sankyo
Fish and Richardson
Baxter

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040716

« Back to Dashboard
NDA 040716 describes METHOTREXATE SODIUM PRESERVATIVE FREE, which is a drug marketed by Accord Hlthcare, Hospira, Mylan Labs Ltd, Sandoz Inc, West-ward Pharms Int, and Pharmachemie Bv, and is included in twelve NDAs. It is available from eight suppliers. Additional details are available on the METHOTREXATE SODIUM PRESERVATIVE FREE profile page.

The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.

Summary for NDA: 040716

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Immunological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040716

Suppliers and Packaging for NDA: 040716

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION 040716 ANDA Accord Healthcare, Inc. 16729-277 16729-277-03 1 VIAL in 1 CARTON (16729-277-03) > 10 mL in 1 VIAL
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION 040716 ANDA Accord Healthcare, Inc. 16729-277 16729-277-30 1 VIAL in 1 CARTON (16729-277-30) > 2 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/40ML (EQ 25MG BASE/ML)
Approval Date:Apr 30, 2007TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Accenture
Harvard Business School
AstraZeneca
Queensland Health
McKinsey
Fuji
Argus Health
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot